Literature DB >> 2166003

Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity.

B Schmekel1, S E Karlsson, M Linden, C Sundström, H Tegner, P Venge.   

Abstract

The origin of myeloperoxidase (MPO) in bronchoalveolar lavage (BAL) was investigated in the first part of the study. Radioimmunoassay of the cellular and supernatant MPO content as well as the peroxidase-antiperoxidase (PAP) technique were employed to determine the cellular source of MPO. The concentrations of MPO were measured in serum and BAL in the second part of the study. The aim was to determine whether the capillary bed was also a source of MPO. Neutrophil numbers in BALs obtained from 20 healthy subjects correlated significantly to the concentrations of MPO in cell-free BAL supernatants (r = 0.643, P less than or equal to 0.01). The cellular content of MPO in mixed BAL cells was significantly correlated to the number of neutrophils in the mixture (r = 0.536, P less than 0.05), but not to the number of any other cells. Moreover, the PAP-technique identified MPO in lung tissue neutrophils in resection specimens obtained from three patients undergoing surgery. This technique also revealed strong MPO activity in all BAL neutrophils and a weak activity in merely 4% of the alveolar macrophages in cytospin preparations obtained from seven BALs. High BAL/serum ratio of MPO concentrations suggests that MPO is of local origin, rather than passively diffused from the circulating pool. We therefore conclude that strong evidence suggests that MPO in BAL originates from lung neutrophils and that BAL MPO content may be used to estimate the neutrophil presence or activation in epithelium lining fluid.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166003     DOI: 10.1007/BF00914095

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  8 in total

1.  Neutrophil and eosinophil granulocytes in bacterial infection: sequential studies of cellular and serum levels of granule proteins.

Authors:  P Venge; A Strömberg; J H Braconier; L E Roxin; I Olsson
Journal:  Br J Haematol       Date:  1978-04       Impact factor: 6.998

2.  Kinetic studies of cell migration in a modified Boyden chamber: dependence on cell concentration and effects of the chymotrypsin-like cationic protein of human granulocytes.

Authors:  P Venge
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

3.  Letter: Substitute for benzidine in myeloperoxidase stains.

Authors:  I S Kaplow
Journal:  Am J Clin Pathol       Date:  1975-03       Impact factor: 2.493

4.  The immunohistological detection of intracellular immunoglobulin in formalin-paraffin sections from multiple myeloma and related conditions using the immunoperoxidase technique.

Authors:  C R Taylor; D Y Mason
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

5.  Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance.

Authors:  J E Weiland; W B Davis; J F Holter; J R Mohammed; P M Dorinsky; J E Gadek
Journal:  Am Rev Respir Dis       Date:  1986-02

6.  Myeloperoxidase in human lung lavage. II. Internalization of myeloperoxidase by alveolar macrophages.

Authors:  B Schmekel; Y Hörnblad; M Linden; C Sundström; P Venge
Journal:  Inflammation       Date:  1990-08       Impact factor: 4.092

7.  Serum myeloperoxidase and lactoferrin in neutropenia.

Authors:  T Olofsson; I Olsson; P Venge; B Elgefors
Journal:  Scand J Haematol       Date:  1977-01

8.  Differentiation of monocytes. Origin, nature, and fate of their azurophil granules.

Authors:  B A Nichols; D F Bainton; M G Farquhar
Journal:  J Cell Biol       Date:  1971-08       Impact factor: 10.539

  8 in total
  28 in total

1.  Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome.

Authors:  A Schnabel; E Csernok; J Braun; W L Gross
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  ANCA-associated diseases and silica exposure.

Authors:  G Gregorini; P Tira; J Frizza; P C D'Haese; M M Elseviers; G Nuyts; R Maiorca; M E De Broe
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

3.  Are women more sensitive than men to 2-propanol and m-xylene vapours?

Authors:  L Ernstgård; E Gullstrand; A Löf; G Johanson
Journal:  Occup Environ Med       Date:  2002-11       Impact factor: 4.402

4.  PYR-41, A Ubiquitin-Activating Enzyme E1 Inhibitor, Attenuates Lung Injury in Sepsis.

Authors:  Shingo Matsuo; Archna Sharma; Ping Wang; Weng-Lang Yang
Journal:  Shock       Date:  2018-04       Impact factor: 3.454

5.  Myeloperoxidase concentration in bronchoalveolar lavage fluid from healthy horses and those with recurrent airway obstruction.

Authors:  Tatiana Art; Thierry Franck; Pierre Lekeux; Brieuc de Moffarts; Laurent Couëtil; Martine Becker; Serge Kohnen; Ginette Deby-Dupont; Didier Serteyn
Journal:  Can J Vet Res       Date:  2006-10       Impact factor: 1.310

6.  IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection.

Authors:  Qun Wu; Richard J Martin; John G Rino; Rachel Breed; Raul M Torres; Hong Wei Chu
Journal:  Microbes Infect       Date:  2006-12-15       Impact factor: 2.700

7.  Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat.

Authors:  Anna Serafín; Joan Roselló-Catafau; Neus Prats; Carme Xaus; Emilio Gelpí; Carmen Peralta
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.

Authors:  Peter J Smit; Weidun A Guo; Bruce A Davidson; Barbara A Mullan; Jadwiga D Helinski; Paul R Knight
Journal:  J Surg Res       Date:  2014-04-08       Impact factor: 2.192

9.  Neutrophil activation in patients with ASA-induced urticaria.

Authors:  Sung-Jin Choi; Young-Min Ye; Gyu-Young Hur; Seung-Youp Shin; Jae-Ho Han; Hae-Sim Park
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

10.  Stimulation of Brain AMP-Activated Protein Kinase Attenuates Inflammation and Acute Lung Injury in Sepsis.

Authors:  Nikhil Mulchandani; Weng-Lang Yang; Mohammad Moshahid Khan; Fangming Zhang; Philippe Marambaud; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  Mol Med       Date:  2015-07-30       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.